Abstract
Technological advancements in robotics, imaging and stereotactic localization have made extracranial radiosurgery possible. Stereotactic body radiation therapy (SBRT) utilizes specially modified linear accelerators to deliver radiation to precisely defined anatomic targets. Radiation is delivered in one to five fractions at high doses per fraction compared to conventional radiation therapy techniques. SBRT was first utilized to treat lesions of the lungs, liver, pancreas and spine but in recent years, there has been a growing body of literature describing the use of this technique in head and neck cancer amongst others. These studies indicate that the treatment is well-tolerated by patients, and in the setting of recurrent head and neck cancer is similar in efficacy to other non-surgical salvage strategies. Optimization of treatment parameters has led to improvements in tumor control while reducing the already low rates of severe chronic toxicities. The promising results to date suggest that SBRT may play an increasing role in the therapeutic armamentarium in head and neck cancer.
Keywords: Clinical outcome, clinical indications, primary or recurrent head and neck cancer, novel therapy, Stereotactic Body Radiotherapy, review.
Current Cancer Therapy Reviews
Title:Stereotactic Body Radiotherapy in the Management of Head and Neck Malignancies
Volume: 10 Issue: 4
Author(s): Jean-Claude M. Rwigema, John A. Vargo, David A. Clump, Robert L. Ferris, James Ohr and Dwight E. Heron
Affiliation:
Keywords: Clinical outcome, clinical indications, primary or recurrent head and neck cancer, novel therapy, Stereotactic Body Radiotherapy, review.
Abstract: Technological advancements in robotics, imaging and stereotactic localization have made extracranial radiosurgery possible. Stereotactic body radiation therapy (SBRT) utilizes specially modified linear accelerators to deliver radiation to precisely defined anatomic targets. Radiation is delivered in one to five fractions at high doses per fraction compared to conventional radiation therapy techniques. SBRT was first utilized to treat lesions of the lungs, liver, pancreas and spine but in recent years, there has been a growing body of literature describing the use of this technique in head and neck cancer amongst others. These studies indicate that the treatment is well-tolerated by patients, and in the setting of recurrent head and neck cancer is similar in efficacy to other non-surgical salvage strategies. Optimization of treatment parameters has led to improvements in tumor control while reducing the already low rates of severe chronic toxicities. The promising results to date suggest that SBRT may play an increasing role in the therapeutic armamentarium in head and neck cancer.
Export Options
About this article
Cite this article as:
Rwigema M. Jean-Claude, Vargo A. John, Clump A. David, Ferris L. Robert, Ohr James and Heron E. Dwight, Stereotactic Body Radiotherapy in the Management of Head and Neck Malignancies, Current Cancer Therapy Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/157339471004150407125823
DOI https://dx.doi.org/10.2174/157339471004150407125823 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biomaterials in Bearing Surface for Total Hip Arthroplasty: State of the Art
Recent Patents on Biomedical Engineering (Discontinued) Brain Tumor Causes, Symptoms, Diagnosis and Radiotherapy Treatment
Current Medical Imaging Prospective Teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and Loss of CYP26 Activity
Current Pharmaceutical Design Challenges in the Correct Assessment of a Case of Aggressive Thyroid Carcinoma with Synchronous Breast Cancer: A Case Report and Review of the Literature of Essential Role of Radiopharmaceuticals
Current Radiopharmaceuticals Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia
CNS & Neurological Disorders - Drug Targets Antioxidants as a Potential Preventive and Therapeutic Strategy for Cadmium
Current Drug Targets Natural Products as Anti-Invasive and Anti-Metastatic Agents
Current Medicinal Chemistry Molecular Properties and Medical Applications of Peptide Nucleic Acids
Mini-Reviews in Medicinal Chemistry Antimicrobial, In Vitro and In Vivo Antineoplastic Activities, Mechanism of Action, Structural and Thermal Properties of a Small-Novel Pharmaceutical Organometallic Chelate
Mini-Reviews in Medicinal Chemistry Interaction Between Retinoids and Eicosanoids: Their Relevance to Cancer Chemoprevention
Current Nutrition & Food Science Combinatorial Application of Nucleic Acid-Based Agents Targeting Protein Kinases for Cancer Treatment
Current Pharmaceutical Design The History of the HSV Amplicon: From Naturally Occurring Defective Genomes to Engineered Amplicon Vectors
Current Gene Therapy The Significance of Transferrin Receptors in Oncology: the Development of Functional Nano-based Drug Delivery Systems
Current Drug Delivery The Molecular Machinery Regulating Apoptosis Signal Transduction and its Implication in Human Physiology and Pathophysiologies
Current Molecular Medicine Anti-inflammatory Action of Green Tea
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry PI-3-Kinase Inhibitors in Colorectal Cancer
Current Cancer Drug Targets Dry Powder Formulation of Plasmid DNA and siRNA for Inhalation
Current Pharmaceutical Design Pharmacogenetics of Non-small Cell Lung Cancer (NSCLC): Time to "Work it Out"?
Current Pharmaceutical Design p53: An Attractive Therapeutic Target for Cancer
Current Medicinal Chemistry Application of Proteomics to Investigate Plant-Microbe Interactions
Current Proteomics